Close

ResMed, Inc. (RMD) Tops Q2 EPS by 2c

January 24, 2013 4:13 PM EST
ResMed, Inc. (NYSE: RMD) reported Q2 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $376.5 million versus the consensus estimate of $363.76 million.

For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings